维普中文期刊产品整合服务
14篇 您的检索式:作者名="Callum JL"
    题名 作者 年代 出处 被引量
1Plasma transfusion for patients with severe hemorrhage: what is the evidence显示文摘Callum JL Rizoli S 2012Transfusion2012,52,:1
2Plasma transfusion for patients with severe hemorrhage: what is the evidence显示文摘Callum JL Rizoli S 2012Transfusion2012,521,:1
3Assessment and management of massive bl_eeding: coagulation assessment, pharmacologic strategies, and transfusion management显示文摘Callum JL Rizoli S 2012Hematology Am Soc Hematol Educ Pro- gram2012,27,7:1
4The Medical Event Reporting System for Transfusion Medicine ( MERS - TM ) : Will it help us get the right blood to the right patient? 显示文摘Kaplan HS Callum JL Rabin FB 2002Trans Med Rev2002,16,2:1
5Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage显示文摘Li J Callum JL Lin Y 2014Haematologica2014,99,:1
6Plasma transfusion for patients with severe hemorrhage what is the evidence? 显示文摘Callum JL Rizoli S 2012Transfusion2012,52,1:1
7Assessment and management of massive bleeding:coagulation assessment, pharmacologic strategies and transfusion management显示文摘Callum JL Rizoli S 2012Hematology Am Soc Hematol Educ Program2012,,:1
8Transfusion of ABOnonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients显示文摘Lin Y Callum JL Coovadia AS 2002Transfusion2002,42,2:1
9Transfusion of ABOnonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients显示文摘Lin Y Callum JL Coovadia AS 2002Transfusion2002,42,2:1
10Plasma transfusion for patients with se- vere hemorrhage:what is the evidence? 显示文摘Callum JL Rizoli S 2012Transfusion2012,,:1
11Reporting of near -miss e- vents fur transfusion medicine: Improving transfusion safety 显示文摘Callum JL Kaplan HS Merkley LL 2001Transfusion2001,41,10:1
12Cryoprecipitate:the current state of knowledge显示文摘Callum JL Karkouti K Lin Y 2009Transfus Med Rev2009,23,:1
13Cryoprecipitate: the current state of knowledge 显示文摘Callum JL Karkouti K Lin Y 2009Transfus Med Rev2009,23,3:1
14冷沉淀的认知现状显示文摘20世纪60年代中期,冷沉淀作为浓集Ⅷ因子被引人,主要用于治疗先天性Ⅷ因子缺乏,而后又被证实治疗血管性血友病和低纤维蛋白原血症有效。现在最常用于获得性低纤维蛋白原血症和大出血患者补充纤维蛋白原。实际上,其组成成分从来没有弄清楚过,也没有设计出合理的临床研究来确定其临床疗效。本文综述自1964年报道冷沉淀以来的文献,希望读者能了解冷沉淀的历史和早期的一些研究热点,从而激发读者进一步认识冷沉淀。Callum JL Karkouti K Lin Y 刘胡敏(节译) 徐伟娟(审校) 2009国际输血及血液学杂志2009,,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费